Hypoxia and the lung: Beyond hypoxic vasoconstriction

Antioxidants and Redox Signaling

Volumn 9, Issue 6, 2007, Pages 741-743

  Nicolls, Mark R ^a   Voelkel, Norbert F ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

BLOOD FLOW; CELL GROWTH; CELL INTERACTION; CELL METABOLISM; CONFERENCE PAPER; DENDRITIC CELL; EOSINOPHIL; HEMATOPOIETIC STEM CELL; HYPOXIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LUNG VASOCONSTRICTION; LYMPHOCYTE; MAST CELL; PRIORITY JOURNAL;

ANIMALS; ANOXIA; HUMANS; LUNG; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 34249062965     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1574     Document Type: Conference Paper

References (28)

1. Altland PD, Highman B, and Smith F. Immune response in rabbits exposed to high altitude. J Infect Disease 113: 228-232, 1963.
2. Davie NJ, Crossno JT Jr, Frid MG, Hofmeister SE, Reeves JT, Hyde DM, Carpenter TC, Brunetti JA, McNieee IK, and Stenmark KR. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am J Physiol 286: L668-L678, 2004.
3. Davie NJ, Gerasimovskaya EV, Hofmeister SE, Richman AP, Jones PL, Reeves JT, and Stenmark KR. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol 168: 1793-1807, 2006.
4. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzwn E, and Jelkmann W, Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25: 297-310, 2005.
5. Jung YJ, Isaacs JS, Lee S, Trepel J, and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17: 2115-2117, 2003.
6. Karakiulakis G, Papakonstantinou E, Aletras AJ, Tamm M, and Roth M. Cell type specific effect of hypoxia and PDGF-BB on extracellular matrix turnover and its consequences for lung remodelling. J Biol Chem 2006 (in press).
7. Kmetz JM and Anthony A. Lymphoidal involution and delayed homograft rejection in hypoxia-exposed mice. Am J Physiol 223: 673-678, 1972.
8. Leclers D, Durand K, Cook-Moreau J, Rabinovitch-Chable H, Sturts FG, and Rigaud M. VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types. Anticancer Res 26: 1885-1891, 2006.
9. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L, Wenger RH, and Sitkovsky M. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform 1.1 negatively regulate functions of CD4+ and CD8+T lymphocytes. J Immunol 177: 4962-4965, 2006.
10. Meehan RT. Immune suppression at high altitude. Ann Emerg Med 16: 974-979, 1987.
11. Moudgil R, Michelakis ED, and Archer SL. The role of K+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 13: 615-632, 2006.
12. Mukhopadhyay S, Xu F, and Sehgal PB. Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia and senescence: subcellular eNOS localization and live-cell caveolar and cytoplasmic NO imaging studies. Am J Physiol Heart Circ Physiol 2006 (in press).
13. Neumann AK, Yang J, Biju MP, Joseph SK, Johnson KS, Haase VH, Freedman BD, and Turka LA. Hypoxia inducible factor I alpha regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A 102: 17071-17076, 2005.
14. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, and Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 26: 986-988, 2006.
15. Ogawa S, Shreeniwas R, Butura C, Brett J, and Stern DM. Modulation of endothelial function by hypoxia: perturbation of barrier and anticoagulant function, and induction of a novel factor X activator. Adv Exp Med Biol 281: 303-312, 1990.
16. Ono S, Westcott JY, and Voelkel NF. PAF-antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol 73: 1084-1092, 1992.
17. Pinsky DJ, Yan SF, Lawson C, Naka Y, Chen JX, Connolly ES Jr., and Stern DM. Hypoxia and modification of the endothelium: implications for regulation of vascular hemostatic properties. Semin Cell Biol 6: 283-294, 1995.
18. Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H, Karibe A, Minegishi N, Suzuki N, Yamamoto M, Ono M, Watanabe J, Shirato K, Ishii N, Sugamura K, and Shimokawa H. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 113: 1142-1450, 2006.
19. Stenmark KR, Fagan KA, and Frid MG. Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res 99: 692-705, 2006.
20. Takeda K and Fong GH. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation. Hypertension 2006 (in press).
21. Tarasevieiene-Stewart L, Kraskaukas D, Scerbavicius K, Burns N, Cool C, Nicolls M, and Voelkel NF. The protective role of T-lymphocytes in pulmonary vascular remodeling. Chest 128: 571S-572S, 2006.
22. Trapani IL. Immunophysiological considerations of antibody formation at high altitude. In: The Physiological Affects of High Altitude, edited by Weihe WH, New York: Macmillan, 1964, pp. 167-175.
23. Tuder RM, Flook BE, and Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposes to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest 95: 1798-1807, 1995.
24. Voelkel NF and Tuder KM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 160: 733-738, 2000.
25. Voelkel NF, Hegstrand L, Reeves JT, McMurtry IF, and Molinoff PB. Decrease in cardiac □-adrenergic receptor density after chronic high altitude exposure. J Appl Physiol 50: 363-366, 1981.
26. Von Euler US and Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12: 301-320, 1946.
27. Wang GL and Semenza GL. Characterization of hypoxia-inducible factor I and regulation of DNA binding activity by hypoxia. J Biol Chem 268: 21513-21518, 1993.
28. Yan SF, Lu J, Xu L, Zou Ys, Tongers J, Kisiel W, Mackman N, Pinsky DJ, and Stern DM. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. J Appl Physiol 88: 2303-2309, 2000.